Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

KU Medical Center to Lead $7.5 Million Male Contraceptive Research and Drug Development Program

Published: Thursday, April 12, 2007
Last Updated: Thursday, April 12, 2007
Bookmark and Share
The University will use the NIH grant to establish a multi-institutional organization that will work to develop new non-hormonal, reversible male contraceptive agents for drug production.

A researcher at the University of Kansas Medical Center has been awarded more than $7.5 million in funding from the National Institutes of Health to lead a team, including researchers at seven universities, in a collaborative effort to develop male contraceptives.

This five-year grant will establish the Interdisciplinary Center for Male Contraceptive Research and Drug Development, a multi-institutional organization that will work to develop new non-hormonal, reversible male contraceptive agents for drug production.

The center will not only consist of research teams at KU Medical Center and KU-Lawrence, but also collaborators across the country at the University of Minnesota, Duke University, the University of California-San Fransisco, Robert Wood Johnson Medical School, and the University of Medicine and Dentistry of New Jersey.

Funding for the center was awarded by the Contraception & Reproductive Health Branch of the National Institute of Child Health and Human Development.

The center will be directed by Joseph Tash, PhD, an associate professor of molecular and integrative physiology at KUMC, and associate director, Dr. Gunda Georg, Chair of Medicinal Chemistry at University of Minnesota. Tash, Georg, and a team of researchers at KUMC and KU Lawrence, have been conducting NIH-funded research, designing and testing male contraceptive agents, for more than five years.

Their work has lead to the development of some promising chemical compounds, such as Gamendazole, one of the most potent new oral anti-spermatogenic agents identified to date. Under this grant, research will continue on Gamendazole as well as exploring new lead compounds.

Tash said the group intends to take a multidisciplinary approach, focusing on several chemical compounds, and proteins that regulate testes function so that mature sperm are not produced. They are also concentrating on chemical agents that may temporarily deactivate enzymes so that sperm development is prevented or sperm are immobilized so the egg remains unfertilized. To identify new lead compounds, the center will utilize High Throughput Screening and proteomics to test hundreds of thousands of compounds.

While High Throughput Screening (HTS) technology is more common in private industry, KU is one of the few universities in the nation to have such a facility, which Tash said is important since many pharmaceutical companies have curtailed their research and development in male contraception. Without the HTS lab, screening hundreds of thousands of compounds could take years, but with the technology, screening time is dramatically reduced to weeks.

The research program in this center will go beyond identifying new protein targets involved in regulation of male fertility, and begin cutting edge drug discovery and design. The scientists involved in the research have a record of success in providing NIH with highly promising reversible non-hormonal male contraceptive agents.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Blocking Previously ‘Undruggable’ Cancer Protein
Researchers from the University of Kansas have found molecular that block previously ‘undruggable’ protein tied to cancer’s onset.
Monday, April 13, 2015
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Thursday, February 05, 2015
KanPro Research Begins Work as 25th KU Startup Company
New startup company designed to tackle protein production.
Friday, June 20, 2014
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Apricot Kernels Pose Risk of Cyanide Poisoning
Eating more than three small raw apricot kernels, or less than half of one large kernel, in a serving can exceed safe levels. Toddlers consuming even one small apricot kernel risk being over the safe level.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
A lncRNA Regulates Repair of DNA Breaks in Breast Cancer Cells
Findings give "new insight" into biology of tough-to-treat breast cancer.
COPD Linked to Increased Bacterial Invasion
Persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung.
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!